 | • レポートコード：MRC309Z7028 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界のES細胞無血清培地の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界のES細胞無血清培地市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - ES細胞無血清培地の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため ES細胞無血清培地市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・基本培地、フィード培地 用途別セグメント ・病院、医学部研究室、医学研究所 主要な市場プレーヤー ・Merck、Thermo Fisher Scientific、Weike Bio Technology、Cyagen、Ajinomoto、Celprogen、Cytiva、InVitria、Kohjin Bio、Miltenyi Biotec、PELOBiotech、R&D Systems、Sartorius、Sigma-Aldrich、Stemcell、Takara Bio 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ES細胞無血清培地製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なES細胞無血清培地メーカーの企業概要、2019年～2022年までのES細胞無血清培地の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なES細胞無血清培地メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別ES細胞無血清培地の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までのES細胞無血清培地の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのES細胞無血清培地市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、およびES細胞無血清培地の産業チェーンを掲載しています。 ・第14、15章では、ES細胞無血清培地の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - ES細胞無血清培地の概要 - 種類別分析（2018年vs2022年vs2029年）：基本培地、フィード培地 - 用途別分析（2018年vs2022年vs2029年）：病院、医学部研究室、医学研究所 - 世界のES細胞無血清培地市場規模・予測 - 世界のES細胞無血清培地生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Merck、Thermo Fisher Scientific、Weike Bio Technology、Cyagen、Ajinomoto、Celprogen、Cytiva、InVitria、Kohjin Bio、Miltenyi Biotec、PELOBiotech、R&D Systems、Sartorius、Sigma-Aldrich、Stemcell、Takara Bio ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：基本培地、フィード培地 ・用途別分析2018年-2029年：病院、医学部研究室、医学研究所 ・ES細胞無血清培地の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ES細胞無血清培地のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ES細胞無血清培地のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ES細胞無血清培地の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ES細胞無血清培地の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Embryonic Stem Cell Serum-free Medium market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Embryonic stem cell serum-free medium is mainly used to cover the culture medium in the stage of in vitro fertilization and embryo culture, and to isolate the culture medium from the external environment during the in vitro operation and culture of gametes and embryos
This report is a detailed and comprehensive analysis for global Embryonic Stem Cell Serum-free Medium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Embryonic Stem Cell Serum-free Medium market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Embryonic Stem Cell Serum-free Medium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Embryonic Stem Cell Serum-free Medium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Embryonic Stem Cell Serum-free Medium market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Embryonic Stem Cell Serum-free Medium
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Embryonic Stem Cell Serum-free Medium market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Thermo Fisher Scientific, Weike Bio Technology, Cyagen and Ajinomoto, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Embryonic Stem Cell Serum-free Medium market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Basal Medium
Feed Medium
Market segment by Application
Hospital
Medical School Laboratory
Medical Research Institute
Major players covered
Merck
Thermo Fisher Scientific
Weike Bio Technology
Cyagen
Ajinomoto
Celprogen
Cytiva
InVitria
Kohjin Bio
Miltenyi Biotec
PELOBiotech
R&D Systems
Sartorius
Sigma-Aldrich
Stemcell
Takara Bio
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Embryonic Stem Cell Serum-free Medium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Embryonic Stem Cell Serum-free Medium, with price, sales, revenue and global market share of Embryonic Stem Cell Serum-free Medium from 2018 to 2023.
Chapter 3, the Embryonic Stem Cell Serum-free Medium competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Embryonic Stem Cell Serum-free Medium breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Embryonic Stem Cell Serum-free Medium market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Embryonic Stem Cell Serum-free Medium.
Chapter 14 and 15, to describe Embryonic Stem Cell Serum-free Medium sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Embryonic Stem Cell Serum-free Medium
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Embryonic Stem Cell Serum-free Medium Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Basal Medium
1.3.3 Feed Medium
1.4 Market Analysis by Application
1.4.1 Overview: Global Embryonic Stem Cell Serum-free Medium Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Medical School Laboratory
1.4.4 Medical Research Institute
1.5 Global Embryonic Stem Cell Serum-free Medium Market Size & Forecast
1.5.1 Global Embryonic Stem Cell Serum-free Medium Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Embryonic Stem Cell Serum-free Medium Sales Quantity (2018-2029)
1.5.3 Global Embryonic Stem Cell Serum-free Medium Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Embryonic Stem Cell Serum-free Medium Product and Services
2.1.4 Merck Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Embryonic Stem Cell Serum-free Medium Product and Services
2.2.4 Thermo Fisher Scientific Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Thermo Fisher Scientific Recent Developments/Updates
2.3 Weike Bio Technology
2.3.1 Weike Bio Technology Details
2.3.2 Weike Bio Technology Major Business
2.3.3 Weike Bio Technology Embryonic Stem Cell Serum-free Medium Product and Services
2.3.4 Weike Bio Technology Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Weike Bio Technology Recent Developments/Updates
2.4 Cyagen
2.4.1 Cyagen Details
2.4.2 Cyagen Major Business
2.4.3 Cyagen Embryonic Stem Cell Serum-free Medium Product and Services
2.4.4 Cyagen Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cyagen Recent Developments/Updates
2.5 Ajinomoto
2.5.1 Ajinomoto Details
2.5.2 Ajinomoto Major Business
2.5.3 Ajinomoto Embryonic Stem Cell Serum-free Medium Product and Services
2.5.4 Ajinomoto Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ajinomoto Recent Developments/Updates
2.6 Celprogen
2.6.1 Celprogen Details
2.6.2 Celprogen Major Business
2.6.3 Celprogen Embryonic Stem Cell Serum-free Medium Product and Services
2.6.4 Celprogen Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Celprogen Recent Developments/Updates
2.7 Cytiva
2.7.1 Cytiva Details
2.7.2 Cytiva Major Business
2.7.3 Cytiva Embryonic Stem Cell Serum-free Medium Product and Services
2.7.4 Cytiva Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cytiva Recent Developments/Updates
2.8 InVitria
2.8.1 InVitria Details
2.8.2 InVitria Major Business
2.8.3 InVitria Embryonic Stem Cell Serum-free Medium Product and Services
2.8.4 InVitria Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 InVitria Recent Developments/Updates
2.9 Kohjin Bio
2.9.1 Kohjin Bio Details
2.9.2 Kohjin Bio Major Business
2.9.3 Kohjin Bio Embryonic Stem Cell Serum-free Medium Product and Services
2.9.4 Kohjin Bio Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kohjin Bio Recent Developments/Updates
2.10 Miltenyi Biotec
2.10.1 Miltenyi Biotec Details
2.10.2 Miltenyi Biotec Major Business
2.10.3 Miltenyi Biotec Embryonic Stem Cell Serum-free Medium Product and Services
2.10.4 Miltenyi Biotec Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Miltenyi Biotec Recent Developments/Updates
2.11 PELOBiotech
2.11.1 PELOBiotech Details
2.11.2 PELOBiotech Major Business
2.11.3 PELOBiotech Embryonic Stem Cell Serum-free Medium Product and Services
2.11.4 PELOBiotech Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 PELOBiotech Recent Developments/Updates
2.12 R&D Systems
2.12.1 R&D Systems Details
2.12.2 R&D Systems Major Business
2.12.3 R&D Systems Embryonic Stem Cell Serum-free Medium Product and Services
2.12.4 R&D Systems Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 R&D Systems Recent Developments/Updates
2.13 Sartorius
2.13.1 Sartorius Details
2.13.2 Sartorius Major Business
2.13.3 Sartorius Embryonic Stem Cell Serum-free Medium Product and Services
2.13.4 Sartorius Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sartorius Recent Developments/Updates
2.14 Sigma-Aldrich
2.14.1 Sigma-Aldrich Details
2.14.2 Sigma-Aldrich Major Business
2.14.3 Sigma-Aldrich Embryonic Stem Cell Serum-free Medium Product and Services
2.14.4 Sigma-Aldrich Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sigma-Aldrich Recent Developments/Updates
2.15 Stemcell
2.15.1 Stemcell Details
2.15.2 Stemcell Major Business
2.15.3 Stemcell Embryonic Stem Cell Serum-free Medium Product and Services
2.15.4 Stemcell Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Stemcell Recent Developments/Updates
2.16 Takara Bio
2.16.1 Takara Bio Details
2.16.2 Takara Bio Major Business
2.16.3 Takara Bio Embryonic Stem Cell Serum-free Medium Product and Services
2.16.4 Takara Bio Embryonic Stem Cell Serum-free Medium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Takara Bio Recent Developments/Updates
3 Competitive Environment: Embryonic Stem Cell Serum-free Medium by Manufacturer
3.1 Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Manufacturer (2018-2023)
3.2 Global Embryonic Stem Cell Serum-free Medium Revenue by Manufacturer (2018-2023)
3.3 Global Embryonic Stem Cell Serum-free Medium Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Embryonic Stem Cell Serum-free Medium by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Embryonic Stem Cell Serum-free Medium Manufacturer Market Share in 2022
3.4.2 Top 6 Embryonic Stem Cell Serum-free Medium Manufacturer Market Share in 2022
3.5 Embryonic Stem Cell Serum-free Medium Market: Overall Company Footprint Analysis
3.5.1 Embryonic Stem Cell Serum-free Medium Market: Region Footprint
3.5.2 Embryonic Stem Cell Serum-free Medium Market: Company Product Type Footprint
3.5.3 Embryonic Stem Cell Serum-free Medium Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Embryonic Stem Cell Serum-free Medium Market Size by Region
4.1.1 Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Region (2018-2029)
4.1.2 Global Embryonic Stem Cell Serum-free Medium Consumption Value by Region (2018-2029)
4.1.3 Global Embryonic Stem Cell Serum-free Medium Average Price by Region (2018-2029)
4.2 North America Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029)
4.3 Europe Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029)
4.4 Asia-Pacific Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029)
4.5 South America Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029)
4.6 Middle East and Africa Embryonic Stem Cell Serum-free Medium Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2029)
5.2 Global Embryonic Stem Cell Serum-free Medium Consumption Value by Type (2018-2029)
5.3 Global Embryonic Stem Cell Serum-free Medium Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2029)
6.2 Global Embryonic Stem Cell Serum-free Medium Consumption Value by Application (2018-2029)
6.3 Global Embryonic Stem Cell Serum-free Medium Average Price by Application (2018-2029)
7 North America
7.1 North America Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2029)
7.2 North America Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2029)
7.3 North America Embryonic Stem Cell Serum-free Medium Market Size by Country
7.3.1 North America Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2018-2029)
7.3.2 North America Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2029)
8.2 Europe Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2029)
8.3 Europe Embryonic Stem Cell Serum-free Medium Market Size by Country
8.3.1 Europe Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2018-2029)
8.3.2 Europe Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Embryonic Stem Cell Serum-free Medium Market Size by Region
9.3.1 Asia-Pacific Embryonic Stem Cell Serum-free Medium Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Embryonic Stem Cell Serum-free Medium Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2029)
10.2 South America Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2029)
10.3 South America Embryonic Stem Cell Serum-free Medium Market Size by Country
10.3.1 South America Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2018-2029)
10.3.2 South America Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Embryonic Stem Cell Serum-free Medium Market Size by Country
11.3.1 Middle East & Africa Embryonic Stem Cell Serum-free Medium Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Embryonic Stem Cell Serum-free Medium Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Embryonic Stem Cell Serum-free Medium Market Drivers
12.2 Embryonic Stem Cell Serum-free Medium Market Restraints
12.3 Embryonic Stem Cell Serum-free Medium Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Embryonic Stem Cell Serum-free Medium and Key Manufacturers
13.2 Manufacturing Costs Percentage of Embryonic Stem Cell Serum-free Medium
13.3 Embryonic Stem Cell Serum-free Medium Production Process
13.4 Embryonic Stem Cell Serum-free Medium Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Embryonic Stem Cell Serum-free Medium Typical Distributors
14.3 Embryonic Stem Cell Serum-free Medium Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer